FDA Inspection 1314364 — Institute for Human Reproduction (IHR) dba Pinnacle Fertility
The FDA completed an inspection of Institute for Human Reproduction (IHR) dba Pinnacle Fertility on April 22, 2026 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chicago, IL (United States)